|
|
WHAT IS ASTHMA? Asthma is defined as a chronic (long term) inflammation of the airways or bronchi of the lungs (the tubes that branch from the wind pipe) that results in intermittent and reversible narrowing of the airways. About 5% of adults and 10% of children in most Western populations have asthma. Symptoms of asthma include breathlessness, wheeze (noisy breathing), and cough. A majority of asthmatics have allergic triggers such as animals danders or dust mites for their symptoms. Asthma attacks (worsening of symptoms) may be provoked by virus infections, allergen exposure, irritants such as smoke or some medicines. Treatment with inhalers or other medication controls asthma for most asthmatics but does not cure the disease and many continue to have symptoms. About 2% of asthmatics are severely limited by their disease despite treatment and up to 1000 people a year die from asthma in the UK.
Types of Asthma Allergic asthma Many asthmatics develop their symptoms in childhood and have asthma triggered by exposure to animals, dust or pollens.
Late onset or non-allergic asthma
Others develop asthma later in life often in their 30s or 40s without any clear external or allergic triggers. This type of asthma is commoner in women and may be related to sensitivity to aspirin and related drugs.
Occupational asthma
Exposure to dusts, chemicals or other agents can cause asthma in the workplace. Investigation of Asthma
If you have asthma this should be assessed by your doctor or an asthma nurse. Investigation will include a history of your symptoms, whether asthma wakes you at night, what provokes them, your work, family history, any history of asthma attacks or admissions to the emergency room or hospital. If you have a history of allergens (cats, dogs, dust, pollens etc) as triggers for asthma symptoms it may be appropriate to have an allergy opinion and skin prick tests. Blowing tests including peak flow (how fast you can blow air out of the lungs) and spirometry (how much air you can blow out in a fixed time and in total) are helpful in assessing asthma and you may be asked to record these in a diary at home.
Management of Asthma
There are national and international guidelines for the diagnosis and management of asthma setting out investigations and treatment including aims and specific medications - British Thoracic Society. In addition there are excellent asthma charities that act as a patient resource with websites and asthma helplines such as (Asthma UK).
Important aims of asthma management are: • Freedom from daytime symptoms • Freedom from night time symptoms
• Freedom from limitation of exercise, work or leisure activities by asthma • Freedom from asthma attacks • Normal lung function (blowing tests within 80% of the average for age, gender and height for non-asthmatics) • Minimal treatment and minimal treatment side effects
It is not always possible to achieve all of these and often there is a balance to be struck between level of treatment and symptoms.
An important principle of asthma management is that asthmatics understand their disease and assume an active part in and responsibility for day to day management and treatment of attacks. This implies understanding medication, triggers and when and how to seek help. To achieve these goals asthma guidelines recommend that each asthmatic has a tailored written asthma management plan specially designed for them.
Asthma Diagnosis
A diagnosis of asthma is usually made on the basis of history (variable symptoms of cough, wheeze and breathlessness) and confirmation of airway narrowing that is variable or can be reversed (usually by peak flow tests over time or before and after a reliever inhaler). Depending on age it may be important to rule out other lung diseases such as infections or inhaled objects in children or COPD (smoking related fixed airway narrowing) in older adults. A chest X ray is usually not required to diagnose asthma but may be helpful in excluding other causes of symptoms. Asthma is often seen together with rhinitis or nasal inflammation and detection and treatment of this may help.
Skin prick tests may be helpful to confirm allergic sensitisation.
Non - Medical Treatment General health promotion will help asthmatics feel better. Thus healthy diet and avoiding obesity are important. Not smoking is important: smokers with asthma do not respond to treatment as well as non smokers and lung function deteriorates more rapidly over time than for smokers without asthma or asthmatics who do not smoke. Although allergen avoidance measures such as mattress covers for dust mites seem intuitively likely to help, recent large trials showed no benefit for either treatment or prevention of asthma. Further studies are needed in targeted patient groups. Specific breathing exercises may be helpful but further research is required.
TREATMENT FOR ASTHMA
Inhalers Inhalers for asthma can be divided intro relievers and controllers. Reliever inhalers relax the airways if they are narrowed and act to give rapid relief of symptoms. These include salbutamol (albuterol in USA). Generally these are blue inhalers and should be used to relieve symptom when they occur or occasionally to avoid symptoms, for example before exercise.
 Relievers do not reduce inflammation of the airways so do not reduce the underlying irritability that causes excess narrowing in responses to smoke, cold or allergens (airway hyperresponsiveness). If relievers are required more than twice a week or at night this suggests the need for a controller inhaler.
Controller inhalers These act to reduce airway inflammation so lessen the likelihood of symptoms developing. Most effective are inhaled steroids such as beclomethasone, fluticasone, budesonide, mometasone or ciclesonide (and flunisolone and triamcinolone in the USA). These should be taken regularly even in the absence of symptoms as their job is to control the disease. Which drug is used, at what dose, in which device and how often (once or twice a day) will depend on each individual case in accordance with the guidelines. Make sure you are happy with, informed about, and involved in the choice for your asthma.
In addition many asthmatics take long acting bronchodilators such as eformoterol or salmeterol: often in combination with the inhaled steroid as a combination inhaler (such as seretide or symbicort). Trial data suggests this approach my improve control and reduce the dose of inhaled steroid required. A combination inhaler may be appropriate if asthma symptoms continue despite use of an inhaled steroid alone. These drugs are usually used on a regular once or twice a day basis but additional use to reduce symptom may be feasible at least for symbicort.
Types of inhalers There are several different types of inhaler device available including metered-dose inhalers (MDI) and dry powder inhalers. Generally MDI devices require good co-ordination between pressing and inhalation. You should decide which is best for you together with the asthma nurse or doctor: the choice depends on the medication you will use. It is clearly sensible to use the same inhaler device for each drug if possible. Over time you my notice local side effects such as hoarseness or loss of voice from inhaled steroids: adding a spacer chamber (such as volumatic) to an MDI may help this: this is a plastic bulb that traps large particles from the inhaler before they lodge in your throat.
Are inhaled steroids safe? Many asthmatics worry about taking steroids because they have heard that they have side effects. Inhaled steroids are generally SAFE. Whilst steroids taken as tablets can have side effects including bone thinning (osteoporosis), diabetes, high blood pressure and cataracts, their use in inhalers and the type of steroid used minimises the amount of drug that affects the body outside the lungs. These drugs have been used for over 30 years. At recommended doses risk of bone changes or other side effects from inhaled steroids are minimal and less than the risk of uncontrolled asthma. Having said that, it is wise to minimise the dose of inhaled steroid to control asthma. Side effects in the throat may occur including hoarseness of the voice. These may be reduced by adding a spacer device.
Tablets for asthma A variety of other drugs are available in tablet form for asthma treatment: generally these are added if symptoms persist despite inhaled steroids.
Antileukotriens These drugs block one of the inflammatory chemicals thought to be involved in airway narrowing and inflammation in asthma. They are taken as tablets once (Montelukast) or twice a day (Zafirlukast). They can be used in mild asthma before inhaled steroids but are generally added to treatment when inhaled steroids do not fully control symptoms. Response seems to vary and like all medication is important to monitor response by symptom and peak flow diary when adding new treatment. Possible side effects include headache, nausea or rash.
Theophyllines These drugs have been used for asthma for many years. Originally used to relax narrowed airways they may also have anti-inflammatory properties and are now added at low dose to inhaled steroids for some asthmatics. Again monitoring response is important. At low doses the need for blood tests to measure drug levels is generally avoided (high doses can be toxic) as is the main side effect of nausea. Steroid tablets Some patients with severe asthma need to take steroid tablets (prednisolone or prednisone) over long periods of time to control disease. This should be monitored by a physician and in conjunction with inhalers and other asthma drugs. There is a trade off between steroid side effects (see above) and risks from severe asthma. The principle side effects are bone thinning (bone density scans are recommended), skin thinning and easy bruising, and cataracts. The dose of oral steroids should always be minimised.
Steroid tablets are also a mainstay of management of asthma attacks given as short bursts (over 5-7 days) they generally restore control. Asthma attacks should be managed in conjunction with your asthma specialist: even if you have a written management plan let your team know if you have an attack.
IF YOU ARE WORRIED SEEK MEDICAL HELP (PHONE OR GO TO HOSPITAL). Difficult asthma A proportion of asthmatics (probably less than 1%) continue to have severe symptoms that interfere with their lives despite the treatments described (high doses of controller inhalers, antileukotrienes or theophyllines and/or oral steroid tablets). This has been termed difficult or difficult to treat asthma.
As with any illness there are many possible reasons that treatment is ineffective: these include incorrect diagnosis: i.e. symptoms are not due to asthma, not taking the prescribed treatment (generally because it was not well explained or particular fears intervened), or co-existing problems at home that prevent good control of asthma. In surveys of difficult asthma these factors account for about half of the cases seen at specialist hospitals. Only by careful and systematic investigation are these potentially treatable problems detected. In the remaining 50% of cases asthma remains problematic despite treatment with inhalers, tables and often oral steroids.
This is the group of patients most at risk from hospital admission or death from asthma and much research is focussed to find new treatments. Possible treatments that have been used include cyclosporine A, methotrexate and more recently monoclonal antibody to IgE or Xolair. Use of these treatments require specialist assessment and monitoring.
Anti-IgE therapy may be appropriate for severe asthma with frequent attacks requiring oral steroids or hospital visits. Trials suggest it could reduce exacerbation rates by 50%. It can be used for patients with allergic asthma with total IgE concentrations in the blood between 30 and 700 units per ml. Expert assessment and monitoring is required. Detailed assessment protocols of difficult asthma have been published. These include specific questionnaires on history, blood tests, lung function, imaging (CT scans), allergy, ENT and physiotherapy assessments. In addition psychological or psychiatric assessment is often valuable. The aim of such intensive investigation is to rule out other causes for symptoms, psychosocial problems or non-concordance with treatment and to characterise different patterns of asthma. Many regional centres now have expert clinics that can provide such investigations.
|
|